Systemic NMDA antagonist CGP-37849 produces non-specific impairment in a working memory task: the effect does not resemble those of AP5 and of lesions of the hippocampus or fornix.
The N-methyl-D-aspartate (NMDA) receptor antagonist CGP-37849 (D,L-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid), administered i.p. (2.0 and 4.0 mg/kg), impaired rats' performance in a delayed matching-to-sample working memory task. This task is sensitive to hippocampal/fornix lesions or i...
Κύριοι συγγραφείς: | Gutnikov, SA, Rawlins, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1996
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effects of the competitive NMDA receptor antagonist CGP 37849 on performance of reference and working memory tasks by rats.
ανά: Deacon, R, κ.ά.
Έκδοση: (1995) -
Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys.
ανά: Gutnikov, SA, κ.ά.
Έκδοση: (1996) -
Determinants of non-spatial working memory deficits in rats given intraventricular infusions of the NMDA antagonist AP5.
ανά: Lyford, G, κ.ά.
Έκδοση: (1993) -
Critical determinants of nonspatial working memory deficits in rats with conventional lesions of the hippocampus or fornix.
ανά: Rawlins, J, κ.ά.
Έκδοση: (1993) -
Effects of GABAB receptor antagonists CGP63360, CGP76290A and CGP76291A on learning and memory processes in rodents
ανά: Getova Damianka, κ.ά.
Έκδοση: (2007-09-01)